Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Inogen
INGN
$154M
| $7.64M | ﹤0.01% |
111,811
+1,884
| +2% | +$118K |
|
1802
Lakeland Financial Corp
LKFN
$1.56B
| $7.64M | ﹤0.01% |
156,130
+3,414
| +2% | +$159K |
|
1803
Douglas Dynamics
PLOW
$967M
| $7.61M | ﹤0.01% |
138,400
+2,092
| +2% | +$106K |
|
1804
Designer Brands
DBI
$312M
| $7.61M | ﹤0.01% |
483,394
+17,895
| +4% | +$297K |
|
1805
Sunrun
RUN
$2.37B
| $7.6M | ﹤0.01% |
550,528
+11,627
| +2% | +$173K |
|
|
MTSC
1806
DELISTED
MTS Systems Corp
MTSC
| $7.6M | ﹤0.01% |
158,243
+175
| +0.1% | +$9.3K |
|
1807
MYR Group
MYRG
$5.1B
| $7.57M | ﹤0.01% |
232,300
-913
| -0.4% | -$30.1K |
|
|
TERP
1808
DELISTED
TerraForm Power, Inc
TERP
| $7.56M | ﹤0.01% |
491,180
+50,292
| +11% | +$811K |
|
|
MODV
1809
DELISTED
ModivCare
MODV
| $7.53M | ﹤0.01% |
127,275
+8,706
| +7% | +$531K |
|
|
ALX
1810
Alexander's
ALX
$1.4B
| $7.53M | ﹤0.01% |
22,794
+10,060
| +79% | +$3.36M |
|
1811
MACOM Technology Solutions
MTSI
$23.5B
| $7.5M | ﹤0.01% |
282,009
+6,143
| +2% | +$147K |
|
1812
PennyMac Financial
PFSI
$4.13B
| $7.5M | ﹤0.01% |
220,367
+4,272
| +2% | +$139K |
|
1813
First Financial Corp
THFF
$975M
| $7.47M | ﹤0.01% |
163,367
+17,322
| +12% | +$764K |
|
1814
Yum China
YUMC
$16.2B
| $7.46M | ﹤0.01% |
155,433
+4,774
| +3% | +$212K |
|
|
EVRI
1815
DELISTED
Everi Holdings
EVRI
| $7.46M | ﹤0.01% |
555,276
+72,887
| +15% | +$832K |
|
|
SWI
1816
DELISTED
SolarWinds Corporation Common Stock
SWI
| $7.45M | ﹤0.01% |
380,804
+7,211
| +2% | +$143K |
|
1817
Fate Therapeutics
FATE
$294M
| $7.44M | ﹤0.01% |
380,212
+38,803
| +11% | +$616K |
|
1818
Vipshop
VIPS
$6.8B
| $7.42M | ﹤0.01% |
523,710
+4,890
| +0.9% | +$57.9K |
|
1819
Dillards
DDS
$9.59B
| $7.42M | ﹤0.01% |
100,928
-725
| -0.7% | -$51.4K |
|
1820
STAAR Surgical
STAA
$1.26B
| $7.41M | ﹤0.01% |
210,576
+4,764
| +2% | +$157K |
|
|
GOOD
1821
Gladstone Commercial Corp
GOOD
$641M
| $7.39M | ﹤0.01% |
338,108
-26,147
| -7% | -$594K |
|
1822
Sonos
SONO
$1.96B
| $7.32M | ﹤0.01% |
468,513
+73,719
| +19% | +$1.03M |
|
1823
BancFirst
BANF
$3.89B
| $7.32M | ﹤0.01% |
117,163
-11,888
| -9% | -$700K |
|
1824
Brown-Forman Class A
BF.A
$13.1B
| $7.31M | ﹤0.01% |
116,463
+1,090
| +0.9% | +$66.9K |
|
|
MSGN
1825
DELISTED
MSG Networks Inc.
MSGN
| $7.3M | ﹤0.01% |
419,803
-201,529
| -32% | -$3.35M |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.